Jefferies Downgrades Salix Pharmaceuticals As Raised Bid By Valeant Appears Final

By: via Benzinga
In a report published Wednesday, Jefferies analyst David Steinberg downgraded the rating on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.